Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00820040 · ClinicalTrials.gov registry record · Phase 2
Feasibility of Permacol Use in Infected Fields
A Phase 2 study, sponsored by Medtronic - MITG.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00820040 is a Phase 2 study that was terminated before completion, run by Medtronic - MITG. The registered enrollment target is 10 participants.
The verdict
NCT00820040, a Phase 2 study, was terminated before completion, sponsored by Medtronic - MITG.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
This pilot study is to examine the feasibility of using Permacol Surgical Implant in the repair of abdominal wall defects after removal of infected prosthetic mesh
Interventions
- DEVICE acellular porcine dermal collagen mesh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00820040
The ClinicalTrials.gov registry entry for NCT00820040 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which acellular porcine dermal collagen mesh is the first listed.
NCT00820040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00820040 about?
NCT00820040 is a clinical study titled "Feasibility of Permacol Use in Infected Fields". This pilot study is to examine the feasibility of using Permacol Surgical Implant in the repair of abdominal wall defects after removal of infected prosthetic mesh
What is the current status of trial NCT00820040?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2009-07. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00820040?
The interventions under investigation include: acellular porcine dermal collagen mesh (DEVICE).
Who is sponsoring clinical trial NCT00820040?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.